HISTOPATHOLOGY INDIA.COM   Atypical Fibroxanthoma

 

              
Syn: Acoustic neuroma ; Schwannoma of the eighth cranial nerve ; Acoustic Neurilemmoma ; Acoustic Neurofibroma.

Schwannoma (neurilemmoma) and variants of the Soft Tissue                         

Vestibular schwannoma is a benign, usually slow-growing, tumour which is usually unilateral. 8% of lesions are bilateral are associated with neurofibromatosis 2.     Visit: Ear Pathology Online  

Site: The tumour usually arises from the vestibular division of the eighth cranial nerve (from the Schwann cells) - 10% of intracranial tumours, 90% of tumours at cerebellopontine angle. In some cases the tumour arises from the cochlear division of the eighth cranial nerve.

Clinical presentation:  Patients complain of hearing loss and tinnitus. As the tumour grows it can cause dizziness/loss of balance and can interfere with the face sensation nerve (the trigeminal nerve), causing facial numbness. Vestibular schwannomas can also press on the facial nerve causing facial weakness or paralysis on the side of the tumour.

The tumour may produce serious symptoms and death by damage to the temporal bone and cerebral structures and by causing increased intracranial pressure.

Gross: Smooth round to oval shaped lobulated tumour, with a yellowish cut surface and areas of hemorrhage.

Microscopic features:  Resemble schwannomas at other locations. There are interlacing fascicles of cells, Antoni A and Antoni B areas together with Verocay bodies and thickened and hyalinized blood vessels. Thrombosis and infarction may be prominent and may be associated with degenerative nuclear atypia.

                  

Histopathology of the inner ear in unoperated acoustic neuroma.Ann Otol Rhinol Laryngol. 2003 Nov;112(11):979-86.

Although hearing loss is the most common presenting symptom in patients with acoustic neuroma, the pathophysiology of hearing loss associated with acoustic neuroma is unknown. Although primary dysfunction of the auditory nerve is intuitively logical, available histopathologic and clinical data suggest that although neural degeneration is common, it alone does not adequately account for hearing loss in many cases. The purpose of this study was to evaluate 11 cases of unoperated unilateral acoustic neuromas. Temporal bones were identified by means of a search mechanism provided by the National Temporal Bone, Hearing, and Balance Pathology Resource Registry and were prepared for light microscopy by standard techniques. Quantification of spiral ganglion cells, hair cells, stria vascularis, and spiral ligament was accomplished for each specimen. In addition, the maximum diameter and volume of each tumor were calculated from histopathologic sections. Increasing tumor size did predict a reduced spiral ganglion count. However, although there was a tendency for decreasing spiral ganglion cell count and for increasing tumor size to predict a higher pure tone average and lower speech discrimination score, these correlations did not reach statistical significance. In tumor ears in which the speech discrimination score was 50% or less, there was always significant degeneration of other structures of the inner ear in addition to neurons, including hair cells, the stria vascularis, and the spiral ligament. Endolymphatic hydrops and eosinophilic precipitate in the perilymphatic spaces were found in 2 of 3 such cases. It is concluded that acoustic neuromas appear to cause hearing loss, not only by causing degeneration of the auditory nerve, but also by inducing degenerative changes in the inner ear. It is hypothesized that the proteinaceous material seen histologically may represent the products of up-regulated genes in acoustic neuroma, some of which may interfere with normal cochlear function.

Clinical tumoral size dissociation in acoustic neuroma: reality or measure distortion?
Acta Otorrinolaringol Esp. 2006 Oct;57(8):345-9.

INTRODUCTION: In this study we have analyzed (i) the audiometric frequencies more often affected in acoustic neuroma (AN), (ii) the percentage of patients presenting normal hearing and those with sudden hearing loss, (iii) if there is a correlation between tumor size and hearing loss, and (iv) the relationship between clinical and radiological parameters and audiological data. METHODS AND MATERIAL: Retrospective study of 81 patients undergoing surgical removal of a sporadic AN. RESULTS: The highest threshold in the tumor's ear was found at 8000 Hz, and the highest interaural difference at 4000 Hz. The percentage of patients presenting normal hearing and sudden hearing loss was 2.5% and 9%, respectively. No significant association was found between tumor size and hearing loss, preoperative facial palsy or Vth cranial nerve deficit. There was a significant association between the degree of hearing loss and Vth cranial nerve deficit, and between hearing loss and preoperative facial palsy. CONCLUSIONS: The association between hearing loss and Vth cranial nerve deficit, and between hearing loss and preoperative facial palsy is independent the size of the tumour.

Translabyrinthine surgery for disabling vertigo in vestibular schwannoma patients.Clin Otolaryngol. 2007 Jun;32(3):167-72.

OBJECTIVE: To determine the impact of translabyrinthine surgery on the quality of life in vestibular schwannoma patients with rotatory vertigo. STUDY DESIGN: Prospective study in 18 vestibular schwannoma patients. SETTING: The study was conducted in a multispecialty tertiary care clinic. PARTICIPANTS: All 18 patients had a unilateral intracanalicular vestibular schwannoma, without serviceable hearing in the affected ear and severely handicapped by attacks of rotatory vertigo and constant dizziness. Despite an initial conservative treatment, extensive vestibular rehabilitation exercises, translabyrinthine surgery was performed because of the disabling character of the vertigo, which considerably continued to affect the patients' quality of life. MAIN OUTCOME MEASURES: Preoperative and postoperative quality of life using the Short Form 36 Health Survey (Short Form-36) scores and Dizziness Handicap Inventory (DHI) scores. RESULTS: A total of 17 patients (94%) completed the questionnaire preoperatively and 3 and 12 months postoperatively. All Short Form-36 scales of the studied patients scored significantly lower when compared with the healthy Dutch control sample (P < 0.05). There was a significant improvement of DHI total scores and Short Form-36 scales on physical and social functioning, role-physical functioning, role-emotional functioning, mental health and general health at 12 months after surgery when compared with preoperative scores (P < 0.05). CONCLUSIONS: Vestibular schwannoma patients with disabling vertigo, experience significant reduced quality of life when compared with a healthy Dutch population. Translabyrinthine tumour removal significantly improved the patients' quality of life. Surgical treatment should be considered in patients with small- or medium-sized tumours and persisting disabling vertigo resulting in a poor quality of life.

Cochlear origin of early hearing loss in vestibular schwannoma.Laryngoscope. 2007 Apr;117(4):680-3. 

OBJECTIVE: To test whether early hearing loss (HL) is cochlear in origin in patients with vestibular schwannoma (VS). STUDY DESIGN: Retrospective case review in an academic tertiary referral center. METHODS: A group of 19 VS patients with normal/symmetrical hearing and a group of 20 VS patients with mild HL (threshold at any tested frequency better than 45 dB HL) on the tumor ear side. Differences of the amplitudes of the distortion products of otoacoustic emissions (DPOAEs) between the tumor ear and the nontumor ear were studied at frequencies of 1, 1.4, 2, 2.8, and 4 kHz. The Wilcoxon test was used to compare the ears for both groups and to test for possible differences in tumor size between groups. RESULTS: DPOAE amplitudes do not differ strongly between the ears in VS patients with normal/symmetrical hearing (two-sided P values: .050 at 1 kHz, .182 at 1.4 kHz, .378 at 2 kHz, .293 at 2.8 kHz, and .238 at 4 kHz) but are decreased compared with the nontumor ear at frequencies 1, 1.4, 2, and 2.8 kHz in VS patients with even mild HL (two-sided P values: .013 at 1 kHz, .007 at 1.4 kHz, .033 at 2 kHz, .010 at 2.8 kHz, and .156 at 4 kHz). Tumor size did not differ significantly between the two groups (P = .436). CONCLUSION: Amplitudes of DPOAEs begin to decrease even at the early stages of HL in VS patients, which suggests a cochlear origin of early HL in these patients. DPOAEs may be used in a clinical setting to monitor progression of cochlear damage at the early stages of hearing impairment in VS patients.

Surgical approaches and complications in the removal of vestibular schwannomas. Otolaryngol Clin North Am. 2007 Jun;40(3):589-609.

Vestibular schwannomas are benign tumors that usually originate from the balance portion of cranial nerve VIII. The treatment options currently available for vestibular schwannomas include observation with serial imaging, stereotactic radiation, and microsurgical removal. Although the ultimate goal in treatment of vestibular schwannomas is preservation of life, the best option for each patient depends on symptoms, tumor size, tumor location, and the patient's general health and age. Surgical exposure of the cerebellopontine angle for removal of vestibular schwannomas can be performed safely via a translabyrinthine, retrosigmoid, and middle fossa approach. Each approach has its advantages and disadvantages. The goal of surgery is complete eradication of tumor with preservation of hearing and facial nerve function when possible.

Cystic vestibular schwannomas.Neurochirurgie. 2004 Jun;50(2-3 Pt 2):401-6.

RATIONALE: Patients with cystic vestibular schwannomas (VS) are a radiologically well-defined subgroup of patients who classically have poor outcome after microsurgical resection. Since Pendl's report of a high rate of failures, they are also considered as poor candidates for radiosurgery. MATERIAL AND METHOD: Among the 1000 consecutive patients who underwent Gamma Knife surgery in Marseilles, France between July 1992 and January 2002, we have collected and studied 54 patients with cystic VS at the time of treatment. RESULTS: The median follow-up of this group was 26 Months (mean: 33, range: 6-90). Failure (6.4%) led to microsurgical removal in 2 patients and a radiosurgery in 1 patient with a delay of 2 Years for 2 of them and 3 Years for the third. No facial palsy has been reported. Two patients developed transient hypesthesia. Among the 32 patients with functional hearing at the time of treatment, 53% preserved their hearing function at 3 Years. CONCLUSIONS: We found an increased risk of failure in this group compared to patients with no cyst at time of radiosurgery (93.6% instead of 98%). But this is also a group were we observe most dramatic shrinkage. Prudent radiosurgical treatment of cystic vestibular schwannomas remains mandatory: strict follow-up is specially important.

Inner ear extension of vestibular schwannomas.Laryngoscope. 2003 Sep;113(9):1605-8.

OBJECTIVE: Inner ear extension of vestibular schwannomas (VSs) is a rare finding but has important clinical implications. This report reviews the treatment options and presents the experience of the Gruppo Otologico, Piacenza, Italy, in this field. STUDY DESIGN: Case report and literature review. METHODS: Five cases of VSs with inner ear extension were surgically removed. In all of them, the cochlea was partially or completely invaded by the lesion. RESULTS: In 4 cases, the inner ear extension was preoperatively identified on magnetic resonance imaging, and the surgical removal was planned through a transotic approach. In the last case, the cochlear invasion was not detected preoperatively, and the lesion was removed during a second surgery performed to seal a cerebrospinal fluid fistula. CONCLUSIONS: VSs with inner ear extension should be distinguished from pure intralabyrinthine schwannomas because of differences in clinical significance. Cochlear involvement is more frequent than vestibular involvement and is often accompanied by a dead ear. Dead ear caused by small VSs should alert the surgeon to the possibility of a cochlear extension. The presence of an intracochlear involvement requires the adoption of an approach that allows control of the cochlear turns, and we found the transotic approach to be the most suitable. Undetected cochlear extensions that are left in place may grow with time.


October 2007

Surgical-Pathology.com

Histopathology-India.net

Pancreatic Pathology Online

Paediatric Pathology Online

Eye Pathology Online

Ear Pathology Online

Cardiac Path Online

Lung Tumour-Online

Mesothelioma-Online

Pulmonary Pathology Online

Nutritional Pathology Online

Environmental Pathology Online

Pathology Quiz Online

Dermpath-India

GI Path Online

Soft Tissue Pathology

Case Index

Infectious Disease Online; INDEX: A-D ; INDEX: E-L ; INDEX: M-P INDEX: Q-Z ; FUNGAL DISEASE ; VIRAL DISEASE.

Angiolymphoid Hyperplasia with Eosinophilia of the External Ear ;

Neoplasms of the External Ear ;

Squamous Cell Carcinoma of the External Ear ;

Verrucous Carcinoma of the External Ear

Basal cell carcinoma of the External Ear ;

Ceruminous Adenoma of the External Ear ;

Pleomorphic Adenoma of the External Ear ;

Syringocystadenoma Papilliferum of the External Ear ;

Cylindroma of the External Ear ;

Ceruminous Adenocarcinoma of the External Ear ;

Adenoid Cystic Carcinoma of the External Ear ;

Melanocytic Tumours of the External Ear ;

Benign Fibro-Osseous Lesion of the External Ear;

Exostosis of the External Ear;

Langerhans Cell Histiocytosis of the Ear;

Primary Lymphoma of the Ear;

Soft Tissue Pathology;

Myxoid Tumours of Soft Tissue

Classification of Soft Tissue Tumour;

Gross examination of soft tissue specimen ;  

A practical approach to histopathological reporting of soft tissue tumours ;

Grading of soft tissue tumours ;

Lipomatous tumours ;

Neural tumours ;

Myogenic tumours ;

Vascular tumours ;

Fibroblastic/Myofibroblastic tumours ;

Myofibroblastic tumours ;

Fibrohistiocytic tumours;

ChondroOsseous tumours ;

Soft TissueTumours of Uncertain Differentiation ;

Notochordal Tumour -Chordoma ;

Extra-adrenal Paraganglioma;

Gastrointestinal Stromal Tumour ;

Reactive and hamartomatous lesions:

Traumatic neuroma

Morton's neuroma

Digital Pacinian neuroma

Nerve Sheath Ganglion

Fibrolipomatous hamartoma of nerve

Benign tumours:

Solitary circumscribed neuroma
(palisaded encapsulated neuroma)

Neurofibroma and variants            

Perineurioma   

Dermal nerve sheath myxoma
(neurothekeoma)

Cellular neurothekeoma

Granular cell tumour

Malignant tumour:

Malignant peripheral nerve sheath tumour
  

Neuroendocrine Carcinoma:

Merkel cell (neuroendocrine) carcinoma

Malignant primitive neuroectodermal tumour   

Miscellaneous neuroectodermal tumours presenting in soft tissue.

Subcutaneous Myxopapillary Ependymoma  

Heterotopic Glial Nodule

Heterotopic Meningeal Lesions